...
首页> 外文期刊>ACS medicinal chemistry letters >FGFR1 Kinase Inhibitors: Close Regioisomers Adopt Divergent Binding Modes and Display Distinct Biophysical Signatures
【24h】

FGFR1 Kinase Inhibitors: Close Regioisomers Adopt Divergent Binding Modes and Display Distinct Biophysical Signatures

机译:FGFR1激酶抑制剂:紧密的区域异构体采用不同的结合模式并显示出不同的生物物理特征

获取原文
获取原文并翻译 | 示例
           

摘要

The binding of a ligand to its target protein is often accompanied by conformational changes of both the protein and the ligand. This is of particular interest, since structural rearrangements of the macromolecular target and the ligand influence the free energy change upon complex formation. In this study, we use X-ray crystallography, isothermal titration calorimetry, and surface-plasmon resonance biosensor analysis to investigate the binding of pyrazolylaminopyrimidine inhibitors to FGFR1 tyrosine kinase, an important anticancer target. Our results highlight that structurally close analogs of this inhibitor series interact with FGFR1 with different binding modes, which are a consequence of conformational changes in both the protein and the ligand as well as the bound water network. Together with the collected kinetic and thermodynamic data, we use the protein-ligand crystal structure information to rationalize the observed inhibitory potencies on a molecular level.
机译:配体与其靶蛋白的结合通常伴随着蛋白和配体的构象变化。这是特别有意义的,因为大分子靶和配体的结构重排影响复合物形成时的自由能变化。在这项研究中,我们使用X射线晶体学,等温滴定热法和表面等离子体共振生物传感器分析来研究吡唑基氨基嘧啶抑制剂与FGFR1酪氨酸激酶(一种重要的抗癌靶标)的结合。我们的结果突出表明,该抑制剂系列的结构紧密类似物以不同的结合模式与FGFR1相互作用,这是蛋白质和配体以及结合的水网络构象变化的结果。连同收集的动力学和热力学数据,我们使用蛋白质-配体晶体结构信息来合理化在分子水平上观察到的抑制能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号